<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01650974</url>
  </required_header>
  <id_info>
    <org_study_id>E-1205-154-002</org_study_id>
    <secondary_id>H-1206-074-414</secondary_id>
    <nct_id>NCT01650974</nct_id>
  </id_info>
  <brief_title>High Flow Nasal OXygen Therapy in High Risk Patients of Hypoxia Undergoing Diagnostic BRONCHOscopy</brief_title>
  <acronym>HFNOT</acronym>
  <official_title>High Flow Nasal OXygen Therapy in High Risk Patients of Hypoxia Undergoing Diagnostic BRONCHOscopy: A Prospective, Randomized, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy and safety of nasal high flow oxygen
      therapy during diagnostic bronchoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypoxemia is frequently seen during diagnostic bronchoscopy. Nasal prong or other existing
      oxygen supply methods are often difficult to maintain adequate oxygenation during
      bronchoscopy. In particular, bronchoscopy to patients already showing hypoxemia can be
      dangerous even though applying conventional oxygen therapy. Thus, we want to elucidate the
      usefulness of nasal high flow oxygen therapy to hypoxemic patients undergoing diagnostic
      bronchoscopy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate of bronchoscopy</measure>
    <time_frame>1 day</time_frame>
    <description>Success is defined as completion of planned diagnostic procedure with the oxygen saturation or partial pressure of oxygen in arterial blood was similar to the level of before the procedure.
Failure is defined as incompletion of planned diagnostic procedure due to sustained hypoxemia or else.
Furthermore failure is defined as hypoxemia(SaO2 &lt;88%) was developed more than 2 times even though planned procedure was completed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total duration of hypoxia</measure>
    <time_frame>1 day</time_frame>
    <description>total duration of hypoxia(oxygen saturation ≤88%) during procedure or after procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>frequency of hypoxia</measure>
    <time_frame>1 day</time_frame>
    <description>frequency of hypoxia(oxygen saturation ≤88%) during procedure or after procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>switch to oxygen therapy method</measure>
    <time_frame>1 day</time_frame>
    <description>Increase oxygen apply or change of oxygen therapy method to high flow system.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of respiratory symptoms</measure>
    <time_frame>1 day</time_frame>
    <description>scoring of dyspnea symptoms, patients comfort.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">152</enrollment>
  <condition>Hypoxia</condition>
  <arm_group>
    <arm_group_label>conventional oxygen therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>conventional nasal prong with FiO2 ~0.4</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HFNOT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high flow nasal oxygen therapy with starting FiO2 0.4 and Flow 40 L/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham-HFNOT</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>same device with FiO2 ~0.4, NO high flow</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HFNOT</intervention_name>
    <description>high flow nasal oxygen therapy</description>
    <arm_group_label>HFNOT</arm_group_label>
    <arm_group_label>sham-HFNOT</arm_group_label>
    <other_name>high flow nasal oxygen therapy(OPTIFLOW)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: 1 or 2

          1. PaO2 &lt; 60 mmHg on ABGA or SpO2 &lt; 90 % in room air AND SpO2 ≥ 95% or PaO2 ≥ 75mmHg in
             low flow oxygen therapy

          2. Planning to diagnostic bronchoscopic procedure (e.g. bronchial washing, BAL,
             bronchoscopic biopsy, EBUS-TBNA etc.)

        Exclusion Criteria:

          1. patients who did not agree to provide information

          2. patients requiring for emergent intubation

          3. patients can not wear or be already applied high flow nasal oxygen therapy

          4. patients with unstable vital sign(e.g. severe hypotension, uncontrolled arrhythmia,
             etc.)

          5. patients with multiple organ failures

          6. patients with plan to therapeutic bronchoscopic procedure(e.g. intervention)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young-Jae Cho, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Young-Jae Cho, MD</last_name>
    <phone>82-10-9925-7058</phone>
    <email>lungdrcho@snubh.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jisoo Park, MD</last_name>
    <phone>82-10-6533-0452</phone>
    <email>subac1@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young-Jae Cho</last_name>
      <phone>82-10-9925-7058</phone>
      <email>lungdrcho@snubh.org</email>
    </contact>
    <contact_backup>
      <last_name>Youlim Kim</last_name>
      <phone>82-10-4447-7551</phone>
      <email>89503@snubh.org</email>
    </contact_backup>
    <investigator>
      <last_name>Young-Jae Cho, MD, MPH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2012</study_first_submitted>
  <study_first_submitted_qc>July 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 26, 2012</study_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Young-Jae Cho</investigator_full_name>
    <investigator_title>Seoul National University Bundang Hospital</investigator_title>
  </responsible_party>
  <keyword>high flow nasal oxygen therapy</keyword>
  <keyword>diagnostic bronchoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

